Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11912737 19-nor neuroactive steroids and methods of use thereof

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Patent Applicant

SAGE Therapeutics

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Francesco G. Salituro0

Gabriel Martinez Botella0

Boyd L. Harrison0

Albert Jean Robichaud0

Richard Thomas Beresis0

Date of Patent

February 27, 2024

0

Patent Application Number

170670930

Date Filed

October 9, 2020

0

Patent Citations

US Patent 8939545 Inkjet printing with managed airflow for condensation control

0

US Patent 9156876 Modified, hydroxy-substituted aromatic structures having cytoprotective activity

0

US Patent 9365611 19-NOR neuroactive steroids and methods of use thereof

0

US Patent 9512165 19-nor C3, 3-disubstituted C21-N-pyrazolyl steroids and methods of use thereof

0

US Patent 9630986 Neuroactive 19-alkoxy-17-substituted steroids, prodrugs thereof, and methods of treatment using same

0

US Patent 9725481 19-nor C3, 3-disubstituted C21-C-bound heteroaryl steroids and methods of use thereof

0

US Patent 9765110 Neuroactive 19-alkoxy-17(20)-Z-vinylcyano-substituted steroids, prodrugs thereof, and methods of treatment using same

0

US Patent 10822370 19-nor neuroactive steroids and methods of use thereof

0

...

Patent Primary Examiner

Yevgeny Valenrod

0

CPC Code

0

0

0

0

0

0

0

0

...

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11912737 19-nor neuroactive steroids and methods of use thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool